Navigation Links
Nontoxic nanoparticle can deliver and track drugs

A nontoxic nanoparticle developed by Penn State researchers is proving to be an all-around effective delivery system for both therapeutic drugs and the fluorescent dyes that can track their delivery.

In a recent online issue of Nano Letters, an interdisciplinary group of materials scientists, chemists, bioengineers, physicists, and pharmacologists show that calcium phosphate particles ranging in size from 20 to 50 nanometers will successfully enter cells and dissolve harmlessly, releasing their cargo of drugs or dye.

Peter Butler, associate professor of bioengineering, and his students used high-speed lasers to measure the size of fluorescent dye-containing particles from their diffusion in solution.

"We use a technique called time correlated single photon counting," Butler says. "This uses pulses of laser light to read the time, on the order of nanoseconds, that molecules fluoresce."

With this method, his group was able to measure the size of the particles and their dispersion in solution, in this case a phosphate-buffered saline that is used as a simple model for blood.

"What we did in this study was to change the original neutral pH of the solution, which is similar to blood, to a more acidic environment, such as around solid tumors and in the parts of the cell that collect the nanoparticles-containing fluid immediately outside the cell membrane and bring it into the cell. When we lower the pH, the acidic environment dissolves the calcium phosphate particle," he adds.

"We can see that the size of the particles gets very small, essentially down to the size of the free dye that was inside the particles. That gives us evidence that this pH change can be used as a mechanism to release any drug that is encapsulated in the particle," Butler explains.

Although the primary use envisioned for these particles is for targeted cancer therapy, Butler's group is interested in their ability to deliver various drugs that have been shown to inhibit cell growth associated with vascular disease.

Several drugs have been shown in cultures to be promising for reducing hardening of the arteries and narrowing of blood vessels after balloon angioplasty. The problem has been in delivering any of these drugs to a target, Butler says.

Ceramide, a chemotherapeutic molecule that initiates cell death in cancer cells, has the ability to slow growth in healthy cells.

Mark Kester, professor of pharmacology, and Jong Yun, associate professor of pharmacology, both at Penn State College of Medicine, have optimized ceramide for both cancer and vascular disease.

Their groups found that by using human vascular smooth muscle cells in vitro, ceramide encapsulated in calcium phosphate nanoparticles reduced growth of muscle cells by up to 80 percent at a dose 25 times lower than ceramide administered freely, without damaging the cells.

The calcium phosphate nanoparticles were developed by James Adair, professor of materials science and engineering, and his students. The nanoparticles have several benefits other drug delivery systems do not, according to lead author Thomas Morgan, graduate student in chemistry.

Unlike quantum dots, which are composed of toxic metals, calcium phosphate is a safe, naturally occurring mineral that already is present in substantial amounts in the bloodstream.

"What distinguishes our method are smaller particles (for uptake into cells), no agglomeration (particles are dispersed evenly in solution), and that we put drugs or dyes inside the particle where they are protected, rather than on the surface," says Morgan. "For reasons we don't yet understand, fluorescent dyes encapsulated within our nanoparticles are four times brighter than free dyes.

"Drugs and dyes are expensive," he continues, "but an advantage of encapsulation is that you need much less of them. We can make high concentrations in the lab, and dilute them way down and still be effective. We even believe we can combine drug and dye delivery for simultaneous tracking and treatment. That's one of the things we are currently working on."


Contact: A'ndrea Elyse Messer
Penn State

Related medicine news :

1. Nanoparticles trigger cell death?
2. Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen
3. Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries
4. New disease-fighting nanoparticles look like miniature pastries
5. Nanoparticles + light = dead tumor cells
6. Using magenetic nanoparticles to combat cancer
7. Nanoparticle Stops Cancer From Spreading
8. Smart bomb nanoparticle strategy impacts metastasis
9. Nanoparticles aid bone growth
10. Magnetic nanoparticles: Suitable for cancer therapy?
11. Brown chemists create cancer-detecting nanoparticles
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: